Tevogen Bio Holdings (TVGN) Change in Cash (2022 - 2026)

Tevogen Bio Holdings has reported Change in Cash for 5 years, with the latest figure at $139933.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 79.78% year-over-year to $139933.0; the trailing twelve-month figure through Mar 2026 stood at -$1.3 million (down 295.22% YoY), and the FY2025 full-year result was -$730623.0, down 416.84% from the prior year.
• Change in Cash for Q1 2026 stood at $139933.0, up from -$484722.0 in the prior quarter.
• The five-year high for Change in Cash was $1.2 million in Q3 2024, with the low at -$2.2 million in Q2 2023.
• Historically, Change in Cash has averaged -$294550.3 across 5 years, with a median of -$45901.0 in 2022.
• The largest YoY upside for Change in Cash was 267.97% in 2023 against a maximum downside of 11112.91% in 2023.
• Tevogen Bio Holdings' Change in Cash stood at -$13861.0 in 2022, then tumbled by 11112.91% to -$1.6 million in 2023, then soared by 32.59% to -$1.0 million in 2024, then soared by 53.73% to -$484722.0 in 2025, then surged by 128.87% to $139933.0 in 2026.
• The last three Change in Cash figures came in at $139933.0 (Q1 2026), -$484722.0 (Q4 2025), and $351865.0 (Q3 2025), per Business Quant data.